Fujian Cancer Hospital: Nasopharyngeal Carcinoma trials

The registry lists 21 Nasopharyngeal Carcinoma studies with Fujian Cancer Hospital as lead sponsor. 11 are open to participants now and 0 have results posted.

Phase 2 9Phase 3 4No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction ChemotherapyNot yet recruitingNCT07399158
• MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPCRecruitingNCT07331428Phase 2
• A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingNCT07252375Phase 2
• Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT07088484
• Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal CancerNot yet recruitingNCT06775756Phase 3
• Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal CarcinomaNot yet recruitingNCT06572293Not applicable
• Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT06331845Phase 2
• Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of LifeNot yet recruitingNCT06136962
• Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPCNot yet recruitingNCT06095167Phase 3
• CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal CarcinomaRecruitingNCT06095154Phase 3
• Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International GuidelinesNot yet recruitingNCT05519956Phase 3
• Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04955886Phase 2
• Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPCStatus unknownNCT04745741
• Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPCStatus unknownNCT04421469Phase 2
• To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPCCompletedNCT04387266
• Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaStatus unknownNCT04319471Phase 2
• Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPCStatus unknownNCT04220528Phase 2
• Nimotuzumab for Recurrent Nasopharyngeal CarcinomaStatus unknownNCT03666221Phase 2
• EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPCStatus unknownNCT03648697Phase 2
• Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal CancerStatus unknownNCT03518489Not applicable
• Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal CarcinomaCompletedNCT02113423Not applicable